The Court rejected a challenge by the generic drug manufacturers Novopharm and Apotex to declare Glaxo Wellcome's patent for AZT, an AIDS-fighting drug, invalid.
•
In February 1985, the NIH reported the positive results of their screening to Glaxo Wellcome, and, on March 16, 1985, Glaxo Wellcome filed a patent application for a new use of AZT in the United Kingdom.
•
One of the drugs screened at that time is what is now known as AZT.
•
In vitro testing on mouse cells revealed that AZT was potentially effective against AIDS.
National Science Foundation | Ford Foundation | Rockefeller Foundation | John Simon Guggenheim Memorial Foundation | Electronic Frontier Foundation | Bill & Melinda Gates Foundation | Wellcome Trust | New York Foundation for the Arts | Mozilla Foundation | Guggenheim Foundation | Alexander von Humboldt Foundation | Andrew W. Mellon Foundation | Wikimedia Foundation | Apache Software Foundation | foundation | Make-A-Wish Foundation | John D. and Catherine T. MacArthur Foundation | Clinton Foundation | Wellcome Trust Sanger Institute | Open Software Foundation | Konex Foundation | Foundation series | Cystic Fibrosis Foundation | Carnegie Foundation | Solomon R. Guggenheim Foundation | McKnight Foundation | Japan Foundation | Ingram Merrill Foundation | Helms Foundation College Basketball Player of the Year | Free Software Foundation |